About Prof. Dr. med. Bertram Glass
Prof. Dr. med. Bertram Glass (also written Glaß) is the Chief Physician of the Department of Hematology and Stem Cell Transplantation at Helios Klinikum Berlin-Buch, Germany, with over 21 years of clinical experience in hematology and over 200 successful bone marrow transplantations performed annually under his supervision. He is internationally recognised with 90+ peer-reviewed publications and 12,091+ scholarly citations, and is the Spokesman for the Aggressive NHL Working Group of the German Lymphoma Alliance.
- 21+ years of clinical experience; 90+ peer-reviewed publications; 12,091+ citations
- Chief Physician, Department of Hematology & Stem Cell Transplantation, Helios Klinikum Berlin-Buch (since 2017)
- Over 200 successful bone marrow transplants performed annually under his supervision
- Spokesman, Aggressive NHL Working Group, German Lymphoma Alliance
- Professor at University Medical Center Göttingen (since 2003)
Qualifications & Credentials
Medical Degrees
- Medical Studies in Human Medicine, Christian-Albrechts-University Kiel, Germany, 1982–1989
- Doctorate (Dr. med. / PhD), Christian-Albrechts-University Kiel, Germany, 1991
- Habilitation and Venia Legendi in Internal Medicine, Christian-Albrechts-University Kiel, Germany, 1999
- Professorship, University Medical Center Göttingen, Germany, 2003
Fellowships & Special Training
- Internship, Christian-Albrechts-University Kiel, Germany, 1989–1991
- Specialist Recognition (Facharzt) in Internal Medicine, Germany, 1996
- Sub-specialty Recognition in Hematology and Cell Therapy, Germany, 2002
Certifications & Accreditations
- State Chamber of Physicians, Berlin (Ärztekammer Berlin) – Registered Specialist in Internal Medicine, Hematology and Cell Therapy
- American Society of Clinical Oncology (ASCO) – Member
- European Society for Medical Oncology (ESMO) – Member
- German Society of Hematology and Oncology (DGHO) – Member
- European Organisation for Research and Treatment of Cancer (EORTC) – Member
- German Interdisciplinary Sarcoma Group (GISG) – Member
- German Lymphoma Alliance – Spokesman, Aggressive NHL Working Group
Areas of Expertise
Major Conditions Treated
- Acute Lymphoblastic Leukaemia (ALL) & Acute Myeloid Leukaemia (AML)
- Hodgkin and Non-Hodgkin Lymphoma (Aggressive NHL)
- Multiple Myeloma
- Myelodysplastic Syndrome (MDS)
- Chronic Myeloproliferative Neoplasia / CMPE
- Aplastic Anaemia
- Benign Blood Diseases
- Disorders of Haematopoiesis
- Bleeding & Coagulation Disorders
- Bone Marrow Failure Syndromes
- Cancer-Related Pain & Palliative Care
- Stem Cell Transplant Candidates of All Ages
Sub-specialties
- Bone Marrow & Stem Cell Transplantation: Performs over 200 successful bone marrow transplantations annually — making him a sought-after hematology specialist in Berlin Germany for international patients seeking the best stem cell transplant centre in Germany.
- Aggressive Lymphoma & CAR-T Cell Therapy: Spokesman of the Aggressive NHL Working Group of the German Lymphoma Alliance and pioneer of CAR-T cell therapy for aggressive lymphoma and certain leukaemias.
- Haploidentical Transplantation: Specialised in haploidentical bone marrow transplantation, including reduced-intensity conditioning for patients over 50.
Advanced Procedures & Treatments
- Autologous Bone Marrow / Stem Cell Transplant
- Allogeneic Bone Marrow / Stem Cell Transplant (Matched, MUD & Haploidentical)
- Reduced-Intensity Conditioning (RIC) Transplantation
- Umbilical Cord Blood Transplantation
- CAR-T Cell Therapy (Aggressive Lymphoma & Leukaemia)
- Chemotherapy & Combination Regimens
- Targeted Therapy
- Antibody Therapy & Immunotherapy
- Bone Marrow Aspiration & Biopsy
- Multidisciplinary Tumour Board Care
- HLA Tissue-Typing for Transplant Matching
- Multicentre Clinical Trial Treatment Pathways
Professional Experience
Current Affiliation
- Helios Klinikum Berlin-Buch, Berlin, Germany — Chief Physician (Chefarzt), Department of Hematology and Stem Cell Transplantation, since 2017 (Present)
- University Medical Center Göttingen, Germany — Professor of Internal Medicine and Hematology, since 2003
Past Affiliations
- Asklepios Klinik St. Georg, Hamburg, Germany — Deputy Head Physician and Section Head, Stem Cell Transplantation, Department of Hematology, Oncology & Stem Cell Transplantation, 2007–2017
- University Medical Center Göttingen, Germany — Head Senior Doctor, Department of Hematology and Oncology, Stem Cell Transplantation Lead, 2002–2007
- University Hospital Göttingen, Germany — Senior Consultant and Head of Hematology & Stem Cell Transplant Centre, 2001
- Christian-Albrechts-University Kiel, Germany — Assistant Doctor & Internship, 1989–2001
Academic & Research Roles
- Professor of Internal Medicine and Hematology, University Medical Center Göttingen (since 2003)
- Habilitation and Venia Legendi for Internal Medicine, Kiel (since 1999)
- Spokesman, Aggressive Non-Hodgkin Lymphoma (NHL) Working Group, German Lymphoma Alliance
- Advisory Board, German Lymphoma Alliance
- Lead and publication of multiple multicentre clinical studies in haematology
- Active member: ASCO, ESMO, DGHO, EORTC, GISG and German Society for Fighting Cancer
Key Achievements
- 21+ years of clinical experience in hematology and stem cell transplantation
- Over 200 successful bone marrow transplants performed annually under his supervision
- 90+ peer-reviewed scientific publications
- 12,091+ scholarly citations
- Chief Physician at Helios Klinikum Berlin-Buch — one of Europe's premier hematology centres
- Pioneer of CAR-T cell therapy in Germany for aggressive lymphoma
Awards & Recognitions
National & International Awards
- Recognised globally for exceptional scientific contributions in hematology and stem cell transplantation
- Spokesman of Aggressive NHL Working Group, German Lymphoma Alliance
- Among Berlin's top hematologists; Helios Berlin-Buch among Europe's best oncohematology departments
- Specific named international awards: Information not publicly available.
Professional Memberships
- American Society of Clinical Oncology (ASCO)
- European Society for Medical Oncology (ESMO)
- German Society of Hematology and Oncology (DGHO)
- European Organisation for Research and Treatment of Cancer (EORTC)
- German Interdisciplinary Sarcoma Group (GISG)
- German Society for Fighting Cancer
- Therapeutic Oncology Society
- German Lymphoma Alliance – Aggressive NHL Working Group Spokesman
Research & Publications
Published Papers (Selected)
- Glass B, et al. Expanding transplant options to patients over 50 years — improved outcome after reduced-intensity conditioning mismatched unrelated donor transplantation for patients with acute myeloid leukemia. Acute Leukemia Working Party of the EBMT.
- Glass B, et al. 90+ peer-reviewed publications and 372+ research contributions on hematology, stem cell transplantation, aggressive lymphoma and CAR-T cell therapy.
- Glass B, et al. 12,091+ scholarly citations across hematology and stem cell transplantation literature.
- Specific full additional citations: Information not publicly available.
Ongoing Research & Clinical Interests
- CAR-T cell therapy for aggressive lymphoma and leukaemia
- Haploidentical and reduced-intensity conditioning bone marrow transplantation
- Aggressive non-Hodgkin lymphoma (NHL)
- Multicentre clinical trials in hematology
- Acute leukaemia transplant outcomes
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (INR) | Estimated Cost (USD) |
|---|---|---|
| Hematology / BMT Consultation | ₹15,000 – ₹35,000 | $180 – $420 |
| Autologous Bone Marrow Transplant | ₹40,00,000 – ₹80,00,000 | $48,000 – $96,000 |
| Allogeneic BMT (Matched / MUD) | ₹60,00,000 – ₹1,30,00,000 | $72,000 – $156,000 |
| Haploidentical BMT | ₹65,00,000 – ₹1,40,00,000 | $78,000 – $168,000 |
| CAR-T Cell Therapy | ₹2,50,00,000 – ₹4,00,00,000 | $300,000 – $480,000 |
| Chemotherapy (per cycle) | ₹1,50,000 – ₹6,00,000 | $1,800 – $7,200 |
| Targeted Therapy / Immunotherapy (per cycle) | ₹6,00,000 – ₹18,00,000 | $7,200 – $21,600 |
*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.
Frequently Asked Questions
1. What advanced technologies does Prof. Dr. med. Bertram Glass use in Pediatric Hematologist treatment?
Prof. Glass uses cutting-edge hematology and cell therapy technologies including CAR-T cell therapy for aggressive lymphoma and leukaemia, autologous, allogeneic and haploidentical stem cell transplantation, reduced-intensity conditioning (RIC) protocols, umbilical cord blood transplantation, modern targeted therapy, antibody therapy and immunotherapy, HLA tissue-typing and structured multicentre clinical trial pathways — making him a top hematology specialist in Berlin, Germany.
2. What conditions does Prof. Dr. med. Bertram Glass specialize in treating?
He specialises in acute lymphoblastic and myeloid leukaemia, Hodgkin and non-Hodgkin lymphoma (especially aggressive NHL), multiple myeloma, myelodysplastic syndrome, chronic myeloproliferative neoplasia / CMPE, aplastic anaemia, benign blood diseases, disorders of haematopoiesis and bone marrow failure syndromes — making him a sought-after Hematology and Stem Cell Transplant specialist in Berlin, Germany.
3. How do I book an appointment with Prof. Dr. med. Bertram Glass?
Appointments with Prof. Dr. med. Bertram Glass can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Prof. Dr. med. Bertram Glass?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Prof. Glass, including medical visa invitation letters, airport transfers, and local accommodation coordination.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations to review medical records before arrival.
6. Does Prof. Dr. med. Bertram Glass offer second opinions for Pediatric Hematologist cases?
Yes. Second opinion consultations with Prof. Glass can be arranged via Cancer Rounds for patients seeking expert review of leukaemia, aggressive lymphoma, multiple myeloma, stem cell transplant or CAR-T cell therapy cases from a Chief Physician of one of Europe's premier hematology centres at Helios Klinikum Berlin-Buch, Germany.
- Germany
